Update on BlincVision development
Terranet is moving closer to the milestone of the first prototype of Terranet’s unique Advanced…
Terranet is moving closer to the milestone of the first prototype of Terranet’s unique Advanced…
TOKYO, Sep 28, 2023 – (JCN Newswire) – Field trial route TOKYO, Sept 28, 2023…
TOKYO, Sep 28, 2023 – (JCN Newswire) – The Campaign Website at “FUN! JAPAN” TOKYO,…
Hong Kong, Sept 28, 2023 – (ACN Newswire) – AEON Credit Service (Asia) Company Limited…
Hong Kong, Sept 28, 2023 – (ACN Newswire) – China’s largest platform-centric decision-making AI company[1]…
Hong Kong, Sept 28, 2023 – (ACN Newswire) – On September 12th, Apple’s annual fall…
Nine in ten US employees rate their mental health positively due to a balanced workload…
Proposed capital increase with preferential subscription rights, to be carried out in January 2024 to…
Strong H1 sales growth (+101%) and significant reduction in current operating loss (-78%) Generated YTD…
Revenue of €4.3 million in the first half of 2023, +4% compared with H1 2022…
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology…
Brighsun EV Group and 2U Chat have embarked on the mass production of one of…
BREXAFEMME Carton BREXAFEMME Blister Pack JERSEY CITY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) — SCYNEXIS,…
MALVERN, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ:…
LA JOLLA, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) (“Faraday Future”, “FF” or “Company”), a…
ELI-002 2P is an investigational therapeutic cancer vaccine targeting solid tumors driven by G12D and…
ELI-002 2P is an investigational therapeutic cancer vaccine targeting solid tumors driven by G12D and…
VANCOUVER, British Columbia, Sept. 27, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or…
VANCOUVER, British Columbia, Sept. 27, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or…